In 1971, Taurel joined
Eli Lilly and Company's subsidiary Eli Lilly International Corporation as a marketing associate. After sales and marketing assignments in
Indianapolis,
São Paulo, and
Paris, he became general manager of the company's affiliate in
Brazil in 1981 and was appointed to the
London-based position of vice president of Lilly European operations in 1983. He was named executive vice president of Eli Lilly and Company and president of its pharmaceutical division in 1993. Three years later, he was promoted to president and chief operating officer. As chairman and CEO from 1998 to 2008, Taurel led the company's efforts to successfully tackle the challenge of the patent loss of its main product Prozac while remaining independent; he drove a deeper globalization of the company, significantly increased its commitment to research and development and partnering, and oversaw the successful launches of a dozen new products, roughly doubling the company's sales. He spoke often on behalf of the pharmaceutical industry, serving as chairman of
Pharmaceutical Research and Manufacturers of America from 1998 to 1999. ==Accolades==